Trial Profile
Perampanel for the control of glioma associated seizures efficacy and safety: a pilot phase II randomised controlled trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Perampanel (Primary) ; Levetiracetam
- Indications Seizures
- Focus Therapeutic Use
- Acronyms PEGASUS-1
- 05 Nov 2021 Status changed from recruiting to discontinued.
- 24 Apr 2019 Planned End Date changed from 31 Mar 2020 to 19 Apr 2022.
- 19 Jul 2017 Status changed from not yet recruiting to recruiting.